Search

everythinglearnresearchcommunity

for

Search:↓

A standardized patch test for hair cosmetics is needed in Europe to prevent allergies, especially for hairdressers.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Peanut allergies can be transferred through organ transplants.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Ebastine may help regrow hair in alopecia areata patients.

Proper nutrition can help balance the immune system and reduce allergies.

Netherton's syndrome is linked to high IgE levels and unique skin and hair symptoms, and may improve with ammonium lactate lotion and allergy management.

Korean patients with rosacea are more likely to have other health conditions.

Microbial biosurfactants could be a safer and environmentally friendly alternative to chemical surfactants in cosmetics.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Azathioprine can cause unusual hair loss, which may reverse after stopping the drug.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

A woman had a skin condition with increased normal elastic fibers, not related to other known disorders, likely due to aging.

Minoxidil helps hair regrowth in alopecia, but more research needed.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Calcipotriol works almost as well as clobetasol for mild to moderate alopecia areata with fewer side effects.

The boy's severe skin disorder is caused by two new mutations in his TGM1 gene.

Patients with Lichen Planopilaris are more likely to have rosacea and skin cancer but less likely to have congestive heart failure, stroke, and glaucoma.

Gold thread implantation may help hair grow in humans and mice.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.